Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00617929 · OUTCOME

Chimerism

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
percentage of donor cells
Interval / dispersion
Full Range
Time frame
Day 28 post transplantation

What was measured

Occurrence of genetically distinct cell types in a single organism

Groups in this outcome

Conditioning for Graft Failure After Transplant

Day -7: Rituximab 375 mg/m2 Day -6: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -5: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -4: Clofarabine 30 mg/m2 IV over 1 hour and Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -3: Clofarabine 30 mg/m2 IV over 1 hour Day -2: Clofarabine 30 mg/m2 IV over 1 hour Day -1: Rest Day 0: Stem Cell Infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Conditioning for Graft Failure After Transplant11

Reported measurements

Source class 1
Values in percentage of donor cells · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Conditioning for Graft Failure After Transplant95Not reported0100Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        100
        value
        95
denoms
  1. counts
    1. group Id
      OG000
      value
      11
    units
    Participants
description
Occurrence of genetically distinct cell types in a single organism
dispersion Type
Full Range
groups
  1. description
    Day -7: Rituximab 375 mg/m2 Day -6: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -5: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -4: Clofarabine 30 mg/m2 IV over 1 hour and Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -3: Clofarabine 30 mg/m2 IV over 1 hour Day -2: Clofarabine 30 mg/m2 IV over 1 hour Day -1: Rest Day 0: Stem Cell Infusion
    id
    OG000
    title
    Conditioning for Graft Failure After Transplant
param Type
MEDIAN
reporting Status
POSTED
time Frame
Day 28 post transplantation
title
Chimerism
type
SECONDARY
unit Of Measure
percentage of donor cells

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice